Drawing for CLINICUVETTE

USPTO serial 78238698

CLINICUVETTE

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
GARTNER, JOHN M
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CLINICUVETTE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

STEWART J BELLUS

STEWART J BELLUS COLLARD & ROE1077 NORTHERN BLVDROSLYN, NY 11576UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001REAGENTS FOR SCIENTIFIC OR MEDICAL RESEARCH USE, NAMELY, DIAGNOSTIC REAGENTS FOR SCIENTIFIC OR RESEARCH LABORATORY USE, REAGENTS FOR THE TRANSFER OF BIOLOGICAL MOLECULES INTO CELLS AND BIOLOGICAL REAGENTS CONTAINING BIOLOGICALLY ACTIVE MOLECULES FOR THE TRANSFER OF THESE MOLECULES INTO CELLS; CHEMICAL PREPARATIONS IN THE NATURE OF FILTERING MATERIALS FOR FILTRATION OF SOLUTIONS CONTAINING BIOLOGICAL MOLECULES AND/OR CELLSABANDONED—
005CELLS TO BE TRANSFECTED WITH BIOLOGICAL MOLECULES, FOR MEDICAL AND VETERINARY USE; REAGENTS FOR CLINICAL OR MEDICAL USEABANDONED—
009LABORATORY EQUIPMENT AND SUPPLIES, NAMELY, CUVETTES, VIALS, TEST TUBES, AND DISPOSABLE RESUASABLE DISPENSER SYRINGES FOR USE IN THE TRANSFER OF BIOLOGICAL MOLECULES INTO CELLSABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 27, 2006MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
Feb 27, 2006ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
Feb 27, 2006OP.TOPPOSITION TERMINATED NO. 999999—
Feb 27, 2006OP.SOPPOSITION SUSTAINED NO. 999999—
Dec 1, 2004OP.IOPPOSITION INSTITUTED NO. 999999—
Jun 16, 2004ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
May 25, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 5, 2004NPUBNOTICE OF PUBLICATION—
Mar 18, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 1, 2004EMRVEMAIL RECEIVED—
Feb 27, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 30, 2003CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Nov 10, 20031.BDSec. 1(B) CLAIM DELETED—
Nov 10, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 10, 2003MAILPAPER RECEIVED—
Sep 10, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2003DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance